The spectacular advances of the ;ast few years resulted in the rapid analysis of the genome sequence of each individual.
The Biomedical world is now faced with the enormous challenges of assigning pathogenicity to each genomic variant, the functional analysis of the genome of each individual, and the accurate and detailed phenotypic characterization. Advances in these challenges are likely to fundamentally change the medical practice in a global scale.
This 2014 HUGO Meeting in Geneva will be a forum for discussions on innovation approaches, and proposals to tacle the anticipated challenges.
Joint Conference of HGM 2013 and 21st International Congress of Genetics
In 2013, HGM and International Congress of Genetics will join forces to stage one of the world's largest knowledge-sharing platforms for the genetics and genomics community. A broader spectrum of topical issues will be discussed in greater depth. Such mighty collaboration in an equally dynamic destination is a first. The joint conference will take place in Singapore, a destination reputed as one of Asia's best cities to hold a business meeting. Larger than her moniker as the "little red dot", Singapore is a bustling cosmopolitan city that offers an enriching experience that is more than just business. Join our mailing list and receive regular updates.
HGM
Human Genome Meeting (HGM) is the key annual conference organised by the Human Genome Organisation (HUGO). Initially structured as a dedicated meeting for Human Genome Mapping, the HGM has evolved into a major scientific conference for human genetics & genomics, genomic medicine, and genomic biology. The HGM is also an excellent platform for industry partners and bio-technology companies as well as pharmaceutical giants. The HGM is optimally sized to provide scientific depth and breadth, and also close interaction amongst the delegates. Because HUGO is not locked in any specific continent or focused on any single country, our HGM conferences take place in a wide range of host countries across Asia, Europe, the Americas, and the Middle East. Therefore, the HGM is the truly global genomics conference.
International Congress of Genetics
The International Congress of Genetics (ICG) is an open conference for geneticists held once every five years since the founding of the science of genetics more than a century ago. The aim of the Congress is to create a venue where researchers from around the world can reflect on progress made in the scientific study of the mechanisms and consequences of biological inheritance, consider the best of contemporary research and anticipate future developments in their discipline. The International Genetics Federation (IGF) sponsors and helps organise each Congress. The congress to be held in 2013 will be the 21st International Congress of Genetics
Though the practice of medicine has always sought to "personalise"Â the care and treatment of patients, the genetics-to-genomics revolution has taken this to the next level with comprehensive, precise, and quantitative genomic technologies. Next generation DNA sequencing, SNP arrays, novel amplification technologies, and microfluidic devices with the accompanying computational advances now speed discovery and the resolution of diagnosis by orders of magnitude. The promise of precise diagnosis, of accurate patient stratification for risk assessment and treatment, and sensitive monitoring is likely to be fulfilled in the next decade. Underpinning all this are the advances in computational biology and eHealth that are necessary to deal with the impending information overload. HGM 2012 will explore the fundamental, translational, and clinical sciences driving the progress of this personalised medicine movement. With the Royal College of Pathologists of Australasia, we will also host a special session on Genomic Pathology to highlight the importance of this discipline to personalised genomic-based medicine...
Visit www.hgm2012.org to find out more!
Genomic technologies provide unheralded precision in identifying the causative genetic mutations in human disease, and uncover new mechanisms of mutagenesis. Genetic disorders represent a significant contribution to the burden of disease in many countries including those in the Middle East. Deciphering the molecular etiology of these genetic disorders is a key priority and will drive healthcare delivery into new dimensions. This HGM 2011 will focus on the genomics and genetics of heritable disorders. We seek to enhance the interaction of international scientists with regional investigators and clinicians and to generate new ideas in human genetics.
View the list of Speakers View the Programme Schedule
This conference jointly organised between the Human Genome Organisation (HUGO) and the International Association of Breast Cancer Research (IABCR) focuses on the intersection of Genomics , Biology, and Breast Cancer Treatment.
Dramatic advances in our understanding of mammary gland development, breast cancer biology, and the genetics of cancer susceptibility have been propelled by genomic strategies and databases. We have redefined cancer classification, revealed the precise contours of estrogen receptor signaling, and identified the mammary gland stem cell. These fundamental advances are now converging to make an impact on the treatment of the disease. In this meeting, we will explore how we arrived to this point, and where we will be going to personalize breast cancer prevention and therapy. This conference will be relevant to clinicians, and researchers who wish to explore the extension of their work into this translational interface. In recognition of this, we will host also educational sessions that will expose basic scientists to clinical breast cancer treatment, and clinicians to the fundamental breast cancer research.
Soon an individual’s genome can be sequenced at accessible cost. Like the availability of books provided by the printing press, the ease of communications by cell phones, and the access to information by the internet, access to information that is broad, deep, and personally significant changes society, its laws, and its sensibilities.
Classical and emerging infectious diseases, viral pandemics, and drug-resistant pathogens remain challenges to human health. However, contemporary advances in genetics and genomic technologies provide new approaches to understanding and combating these diseases.
Wednesday, 19 June 2013 09:40 pm
.jpg)
